Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Keeping blood pressure in check may benefit some African-Americans with kidney disease

07.10.2010
Keeping blood pressure at a low level in African-Americans with kidney disease may slow the progression of the condition in patients with proteinuria, UT Southwestern Medical Center researchers found in a national study published in The New England Journal of Medicine.

In the African-American Study of Kidney Disease and Hypertension, or AASK, trial of 1,094 patients, researchers found that keeping blood pressure readings at about 130/80 mm Hg reduced the risk of disease progression by 27 percent for patients with protein in the urine (proteinuria), which can be a marker for kidney disease. Intensive lowering of blood pressure in all African-Americans with hypertension and kidney disease, however, did not slow disease progression during four years of follow-up.

Overall, lower blood pressure levels had no effect on disease progression to dialysis, kidney transplantation or death when those with and without proteinuria were included.

"We were surprised by the study's finding that more intensive lowering of blood pressure initially did not improve outcomes for most patients," said Dr. Robert Toto, professor of internal medicine and clinical sciences at UT Southwestern and an author of the study. "During the cohort study all patients had their blood pressure lowered to less than 130/80 mm Hg, and we found that those with proteinuria who were assigned to more aggressive blood pressure control during the trial fared better in the long run. We are very proud of the fact that we were able to extend the results of the trial and learn more about progression of kidney disease in this population.

"Doctors should think about the long-term effects reported in this new study and consider whether it is appropriate to control blood pressure more aggressively in African-American patients with chronic kidney disease who have protein in their urine, and not target all kidney disease patients with a lower blood pressure level. We need more studies on any potential benefits of that practice."

In 2006, treating end-stage kidney disease cost the federal government $23 billion, and chronic kidney disease cost $49 billion. In the U.S., hypertension causes about 30 percent of end-stage kidney disease. African-Americans make up a disproportionate number of patients with end-stage kidney disease attributed to hypertension.

Observational studies have shown that treating kidney-disease patients to help them achieve lower blood pressure has prevented progression to end-stage kidney disease, but few formal trials have tested the idea. In the limited studies that have, African-Americans were not well-represented.

In the current study, patients ranged in age from 18 to 70, with an average age of 55. Nearly 40 percent of the patients were female. The patients came from 21 centers throughout the United States; 77 patients were treated at UT Southwestern.

To test if a lower blood pressure goal would help African-Americans with chronic kidney disease, AASK researchers broke the study into two phases. From 1995 to 1998, patients were randomly assigned 1,094 to receive either intensive blood pressure treatment to reach levels below 130/80 mm Hg, or standard blood pressure control of 140/90 mm Hg. They were monitored for three and six years.

After completion of the trial, a second phase known as the AASK cohort study included patients who were then switched to the same medication, and all eventually had a blood pressure target of 130/80 mm Hg. Blood pressure levels and hypertension were monitored every two years for patients whose disease had not progressed. Some patients were followed for up to 12 years.

Based on evidence emerging from other studies, AASK researchers also analyzed their data based on how much protein was found in each patient's urine. About one-third of patients had protein in the urine.

Among those patients, the risk of disease progression was reduced by 27 percent – a significant difference, Dr. Toto said.

"UT Southwestern was involved in the pilot study back in 1992, as well as in the 12 years of follow-up through the end of the cohort study," Dr. Toto said. "We're at the forefront of ensuring that clinical practice follows evidence."

Others researchers at UT Southwestern involved in the study include Dr. Gail Peterson, associate professor of internal medicine; Dr. Ramesh Saxena, associate professor of internal medicine; and Tammy Lightfoot, clinical research manager in internal medicine.

The study was funded by the National Institutes of Health. King Pharmaceuticals provided financial support and donated anti-hypertensive medications to each clinical center. Pfizer, AstraZeneca, GlaxoSmithKline, Forest Laboratories, Pharmacia and Upjohn also donated anti-hypertension medications.

Visit http://www.utsouthwestern.org/kidneys to learn more about UT Southwestern's clinical services for kidney diseases and conditions. Visit http://www.utsouthwestern.org/heartlungvascular to learn more about heart, lung and vascular clinical services, including the hypertension program, at UT Southwestern.

This news release is available on our World Wide Web home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via e-mail, subscribe at www.utsouthwestern.edu/receivenews

LaKisha Ladson | EurekAlert!
Further information:
http://www.utsouthwestern.edu

More articles from Health and Medicine:

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

nachricht High speed video recording precisely measures blood cell velocity
15.11.2017 | ITMO University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

NASA detects solar flare pulses at Sun and Earth

17.11.2017 | Physics and Astronomy

NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures

17.11.2017 | Health and Medicine

The importance of biodiversity in forests could increase due to climate change

17.11.2017 | Studies and Analyses

VideoLinks
B2B-VideoLinks
More VideoLinks >>>